Molecular Characteristics of Carbapenem-Resistant Enterobacter cloacae in a Tertiary Hospital in China

References

• Wang S, Xiao SZ, Gu FF, et al. Antimicrobial susceptibility and molecular epidemiology of clinical Enterobacter cloacae bloodstream isolates in Shanghai, China. PLoS One. 2017;12(12):e0189713. doi:10.1371/journal.pone.018971329244831
   PubMed Web of Science ®Google Scholar
• Liu C, Qin S, Xu H, et al. New Delhi Metallo-beta-Lactamase 1(NDM-1), the dominant carbapenemase detected in carbapenem-resistant Enterobacter cloacae from Henan Province, China. PLoS One. 2015;10(8):e0135044. doi:10.1371/journal.pone.013504426263489
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-0717630334
   PubMed Web of Science ®Google Scholar
• Bush K. Carbapenemases: partners in crime. J Glob Antimicrob Resist. 2013;1(1):7–16. doi:10.1016/j.jgar.2013.01.00527873609
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707. doi:10.1128/CMR.05035-1123034326
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35(1):147–151. doi:10.1128/AAC.35.1.1471901695
   PubMed Web of Science ®Google Scholar
• Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother. 1994;38(1):71–78. doi:10.1128/AAC.38.1.718141584
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Peirano G, Motyl MR, et al. Global molecular epidemiology of IMP-producing enterobacteriaceae. Antimicrob Agents Chemother. 2017;61:4. doi:10.1128/AAC.02729-16
   Web of Science ®Google Scholar
• Lewis JS 2nd, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007;51(11):4015–4021. doi:10.1128/AAC.00576-0717724160
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang H, Sun H, Chen H, Xu Y, Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob Agents Chemother. 2010;54(1):573–577. doi:10.1128/AAC.01099-0919805565
   PubMed Web of Science ®Google Scholar
• Jolley KA, Feil EJ, Maiden M-SC. Sequence type analysis and recombinational tests (START)\n. Bioinformatics. 2001;12:12.
   Google Scholar
• Cui L, Zhao J, Lu J. Molecular characteristics of extended spectrum beta-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital. Turk J Med Sci. 2015;45(6):1321–1328. doi:10.3906/sag-1407-6226775390
   PubMed Web of Science ®Google Scholar
• Fernández J, Montero I, Martínez Ó, et al. Dissemination of multiresistant Enterobacter cloacae isolates producing OXA-48 and CTX-M-15 in a Spanish hospital. Int J Antimicrob Agents. 2015;46(4):469–474. doi:10.1016/j.ijantimicag.2015.07.00326307466
   PubMed Web of Science ®Google Scholar
• Kiedrowski LM, Guerrero DM, Perez F, et al. Carbapenem-resistant enterobacter cloacae isolates producing KPC-3, North Dakota, USA. Emerg Infect Dis. 2014;20(9):1583–1585. doi:10.3201/eid2009.14034425153967
   PubMed Web of Science ®Google Scholar
• Sidjabat HE, Townell N, Nimmo GR, et al. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia. Antimicrob Agents Chemother. 2015;59(7):4059–4066. doi:10.1128/AAC.04378-1425918153
   PubMed Web of Science ®Google Scholar
• Villa J, Viedma E, Branas P, Orellana MA, Otero JR, Chaves F. Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid. Int J Antimicrob Agents. 2014;43(5):451–455. doi:10.1016/j.ijantimicag.2014.02.00624702943
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012-2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy66030423057
   PubMed Web of Science ®Google Scholar
• Koh TH, Khoo CT, Tan TT, et al. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene. J Clin Microbiol. 2010;48(7):2563–2564. doi:10.1128/JCM.01905-0920463166
   PubMed Web of Science ®Google Scholar
• Tada T, Nhung PH, Miyoshi-Akiyama T, et al. Multidrug-resistant sequence type 235 pseudomonas aeruginosa clinical isolates producing IMP-26 with increased carbapenem-hydrolyzing activities in Vietnam. Antimicrob Agents Chemother. 2016;60(11):6853–6858. doi:10.1128/AAC.01177-1627600046
   PubMed Web of Science ®Google Scholar
• Zhao Q, Jia X, Pang F, Li Y. Study on genotype and clinical characteristics of infection of carbapenemase-producing Enterobacter cloacae. Med J China. 2015;95(40):3264–3268.
   Google Scholar
• Wang S, Zhou K, Xiao S, et al. A multidrug resistance plasmid pIMP26, carrying blaIMP-26, fosA5, blaDHA-1, and qnrB4 in Enterobacter cloacae. Sci Rep. 2019;9(1):10212. doi:10.1038/s41598-019-46777-631308469
   PubMed Web of Science ®Google Scholar
• Xia Y, Liang Z, Su X, Xiong Y. Characterization of carbapenemase genes in Enterobacteriaceae species exhibiting decreased susceptibility to carbapenems in a university hospital in Chongqing, China. Ann Lab Med. 2012;32(4):270–275. doi:10.3343/alm.2012.32.4.27022779068
   PubMed Web of Science ®Google Scholar
• Dai W, Sun S, Yang P, Huang S, Zhang X, Zhang L. Characterization of carbapenemases, extended spectrum beta-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing. Infect Genet Evol. 2013;14:1–7. doi:10.1016/j.meegid.2012.10.01023220359
   PubMed Web of Science ®Google Scholar
• Cai Y, Chen C, Zhao M, et al. High prevalence of metallo-beta-lactamase-producing Enterobacter cloacae from three Tertiary Hospitals in China. Front Microbiol. 2019;10:1610. doi:10.3389/fmicb.2019.0161031447788
   PubMed Web of Science ®Google Scholar
• Harada K, Shimizu T, Mukai Y, et al. Phenotypic and molecular characterization of antimicrobial resistance in Enterobacter spp. isolates from companion animals in Japan. PLoS One. 2017;12(3):e0174178. doi:10.1371/journal.pone.017417828328967
   PubMed Web of Science ®Google Scholar
• Gomez-Simmonds A, Hu Y, Sullivan SB, Wang Z, Whittier S, Uhlemann AC. Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14. J Antimicrob Chemother. 2016;71(8):2351–2353. doi:10.1093/jac/dkw13227118776
   PubMed Web of Science ®Google Scholar
• Jin C, Zhang J, Wang Q, et al. Molecular characterization of carbapenem-resistant Enterobacter cloacae in 11 Chinese cities. Front Microbiol. 2018;9:1597. doi:10.3389/fmicb.2018.0159730065717
   PubMed Web of Science ®Google Scholar
• Gomez-Simmonds A, Annavajhala MK, Wang Z, et al. Genomic and geographic context for the evolution of high-risk carbapenem-resistant enterobacter cloacae complex clones ST171 and ST78. mBio. 2018;9:3. doi:10.1128/mBio.00542-18
   Web of Science ®Google Scholar
• Izdebski R, Baraniak A, Herda M, et al. MLST reveals potentially high-risk international clones of Enterobacter cloacae. J Antimicrob Chemother. 2015;70(1):48–56. doi:10.1093/jac/dku35925216820
   PubMed Web of Science ®Google Scholar
• Kanamori H, Parobek CM, Juliano JJ, et al. A prolonged outbreak of KPC-3-producing enterobacter cloacae and klebsiella pneumoniae driven by multiple mechanisms of resistance transmission at a large academic burn center. Antimicrob Agents Chemother. 2017;61:2. doi:10.1128/AAC.01516-16
   Web of Science ®Google Scholar
• Miao M, Wen H, Xu P, et al. Genetic diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) clinical isolates from a Tertiary Hospital in Eastern China. Front Microbiol. 2018;9:3341. doi:10.3389/fmicb.2018.0334130697205
   PubMed Web of Science ®Google Scholar
• Li S, Guo FZ, Zhao XJ, et al. Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China. Infect Drug Resist. 2019;12:1407–1414. doi:10.2147/IDR.S20164431213858
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Y, Yao X, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35(10):1679–1689. doi:10.1007/s10096-016-2710-027401905
   PubMed Web of Science ®Google Scholar